PCM
KRRO icon

Penserra Capital Management’s Korro Bio KRRO Stock Holding History

Penserra Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16
Closed -$5K – 1460
2021
Q3 		$5K Hold
16
– – ﹤0.01% 1408
2021
Q2 		$7K Buy
16
+1
+7% +$488 ﹤0.01% 1296
2021
Q1 		$7K Sell
15
-1
-6% -$1.94K ﹤0.01% 1063
2020
Q4 		$27K Buy
+16
New +$21.1K ﹤0.01% 808

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Penserra Capital Management's KRRO Position: Q4 2021 in Review

Penserra Capital Management sold out of Korro Bio (KRRO) in Q4 2021, closing a stake of 16 shares — an estimated $5K sold.

Penserra Capital Management first reported a position in KRRO in Q4 2020 and held it in 4 quarters. The position peaked at $27K in Q4 2020. 82 funds tracked by Wall St. Rank hold KRRO as of Q4 2021.

  • Penserra Capital Management reported no remaining Korro Bio position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 16 Korro Bio shares in Q4 2021, an estimated $5K.
  • Penserra Capital Management first reported a position in Korro Bio in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's Korro Bio position peaked at $27K in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Korro Bio as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.